JP2011042653A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011042653A5 JP2011042653A5 JP2010200550A JP2010200550A JP2011042653A5 JP 2011042653 A5 JP2011042653 A5 JP 2011042653A5 JP 2010200550 A JP2010200550 A JP 2010200550A JP 2010200550 A JP2010200550 A JP 2010200550A JP 2011042653 A5 JP2011042653 A5 JP 2011042653A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- branched
- linear
- atom
- optically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 Cc1n[n]2c(C)c(*)c(***)c(*)c2n1 Chemical compound Cc1n[n]2c(C)c(*)c(***)c(*)c2n1 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0105407A HUP0105407A3 (en) | 2001-12-21 | 2001-12-21 | Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554684A Division JP4724366B2 (ja) | 2001-12-21 | 2002-12-17 | アデノシン受容体リガンドとして有用なトリアゾロ−キノリン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011042653A JP2011042653A (ja) | 2011-03-03 |
| JP2011042653A5 true JP2011042653A5 (enExample) | 2011-12-08 |
Family
ID=90001529
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554684A Expired - Fee Related JP4724366B2 (ja) | 2001-12-21 | 2002-12-17 | アデノシン受容体リガンドとして有用なトリアゾロ−キノリン誘導体 |
| JP2010200550A Withdrawn JP2011042653A (ja) | 2001-12-21 | 2010-09-08 | アデノシン受容体リガンドとして有用なトリアゾロ−キノリン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003554684A Expired - Fee Related JP4724366B2 (ja) | 2001-12-21 | 2002-12-17 | アデノシン受容体リガンドとして有用なトリアゾロ−キノリン誘導体 |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7365089B2 (enExample) |
| EP (1) | EP1456204A1 (enExample) |
| JP (2) | JP4724366B2 (enExample) |
| KR (1) | KR100934796B1 (enExample) |
| CN (1) | CN1307175C (enExample) |
| AU (1) | AU2002353240B2 (enExample) |
| BR (1) | BR0215276A (enExample) |
| CA (1) | CA2470064C (enExample) |
| EA (1) | EA007066B1 (enExample) |
| HR (1) | HRP20040672A2 (enExample) |
| HU (2) | HUP0105407A3 (enExample) |
| IL (2) | IL162444A0 (enExample) |
| IS (1) | IS7318A (enExample) |
| MA (1) | MA27094A1 (enExample) |
| MX (1) | MXPA04006113A (enExample) |
| NO (1) | NO329757B1 (enExample) |
| NZ (1) | NZ534016A (enExample) |
| PL (1) | PL370747A1 (enExample) |
| RS (1) | RS56004A (enExample) |
| TN (1) | TNSN04106A1 (enExample) |
| UA (1) | UA79955C2 (enExample) |
| WO (1) | WO2003053968A1 (enExample) |
| ZA (1) | ZA200404802B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0105407A3 (en) * | 2001-12-21 | 2004-04-28 | Sanofi Aventis | Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
| HUP0203976A3 (en) | 2002-11-15 | 2004-08-30 | Sanofi Aventis | Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them |
| HUP0400812A2 (en) * | 2004-04-19 | 2006-02-28 | Sanofi Aventis | Crystalline forms of 2-amino-3-cyano-quinoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| US20050288502A1 (en) * | 2004-06-25 | 2005-12-29 | Andersen Denise L | Substituted heterocyclic compounds and methods of use |
| CN102702316A (zh) * | 2006-11-30 | 2012-10-03 | 首都医科大学 | 具有靶向抗血栓活性的rgdfyigsk、制备和应用 |
| CN102702314A (zh) * | 2006-11-30 | 2012-10-03 | 首都医科大学 | 具有靶向抗血栓活性的rgdfyigsr、制备和应用 |
| CN102702312A (zh) * | 2006-11-30 | 2012-10-03 | 首都医科大学 | 具有靶向抗血栓活性的rgdvyigsk、制备和应用 |
| CN102702313A (zh) * | 2006-11-30 | 2012-10-03 | 首都医科大学 | 具有靶向抗血栓活性的rgdvyigsr、制备和应用 |
| CN102702315A (zh) * | 2006-11-30 | 2012-10-03 | 首都医科大学 | 具有靶向抗血栓活性的rgdsyigsk、制备和应用 |
| HUP0700395A2 (en) * | 2007-06-07 | 2009-03-02 | Sanofi Aventis | Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates |
| DE102007061763A1 (de) * | 2007-12-20 | 2009-06-25 | Bayer Healthcare Ag | Substituierte azabicyclische Verbindungen und ihre Verwendung |
| DK2950649T3 (da) | 2013-02-01 | 2020-05-04 | Wellstat Therapeutics Corp | Aminforbindelser med antiinflammations-, antisvampe-, antiparasit- og anticanceraktivitet |
| CN108358927B (zh) * | 2018-01-26 | 2020-09-01 | 郑州大学 | 1,4-二取代1,2,3-三氮唑核苷类似物及其制备方法和应用 |
| CN119302957B (zh) * | 2023-07-14 | 2025-11-21 | 同济大学 | 三唑并喹啉衍生物在制备预防或治疗疟疾的药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE280109C (enExample) | ||||
| DE280110C (enExample) | ||||
| GB1479759A (en) * | 1974-11-23 | 1977-07-13 | Lepetit Spa | Heterocyclic fused derivatives of indole and quinoline |
| DD280109A1 (de) * | 1989-02-22 | 1990-06-27 | Univ Berlin Humboldt | Verfahren zur herstellung substituierter 1.2.4-triazolo/1.5-a/-pyridine |
| DD280110A1 (de) * | 1989-02-22 | 1990-06-27 | Univ Berlin Humboldt | Verfahren zur herstellung von 1.2.4-triazolo/1.5-a/-pyridin-8-carbonitrilen |
| DE3926770A1 (de) * | 1989-08-12 | 1991-02-14 | Basf Ag | (1,2,4)triazolo(1,5-a)pyridine |
| JP4431638B2 (ja) * | 1996-01-29 | 2010-03-17 | アメリカ合衆国 | ジヒドロピリジン―、ピリジン―、ベンゾピラン―オン―およびトリアゾロキナゾリン誘導体、それらの製造およびそれらのアデノシン受容体アンタゴニストとしての用途 |
| US5780481A (en) * | 1996-08-08 | 1998-07-14 | Merck & Co., Inc. | Method for inhibiting activation of the human A3 adenosine receptor to treat asthma |
| US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
| US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| HUP0105407A3 (en) | 2001-12-21 | 2004-04-28 | Sanofi Aventis | Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates |
-
2001
- 2001-12-21 HU HU0105407A patent/HUP0105407A3/hu unknown
-
2002
- 2002-12-17 HU HU0402282A patent/HUP0402282A3/hu unknown
- 2002-12-17 US US10/499,250 patent/US7365089B2/en not_active Expired - Fee Related
- 2002-12-17 KR KR1020047009789A patent/KR100934796B1/ko not_active Expired - Fee Related
- 2002-12-17 JP JP2003554684A patent/JP4724366B2/ja not_active Expired - Fee Related
- 2002-12-17 EP EP02788260A patent/EP1456204A1/en not_active Withdrawn
- 2002-12-17 PL PL02370747A patent/PL370747A1/xx not_active Application Discontinuation
- 2002-12-17 RS YU56004A patent/RS56004A/sr unknown
- 2002-12-17 IL IL16244402A patent/IL162444A0/xx unknown
- 2002-12-17 HR HR20040672A patent/HRP20040672A2/xx not_active Application Discontinuation
- 2002-12-17 AU AU2002353240A patent/AU2002353240B2/en not_active Ceased
- 2002-12-17 MX MXPA04006113A patent/MXPA04006113A/es active IP Right Grant
- 2002-12-17 UA UA20040706067A patent/UA79955C2/uk unknown
- 2002-12-17 NZ NZ534016A patent/NZ534016A/en not_active IP Right Cessation
- 2002-12-17 CA CA2470064A patent/CA2470064C/en not_active Expired - Fee Related
- 2002-12-17 BR BR0215276-2A patent/BR0215276A/pt not_active IP Right Cessation
- 2002-12-17 CN CNB028256468A patent/CN1307175C/zh not_active Expired - Fee Related
- 2002-12-17 EA EA200400848A patent/EA007066B1/ru not_active IP Right Cessation
- 2002-12-17 WO PCT/HU2002/000143 patent/WO2003053968A1/en not_active Ceased
-
2004
- 2004-06-07 MA MA27724A patent/MA27094A1/fr unknown
- 2004-06-08 TN TNP2004000106A patent/TNSN04106A1/en unknown
- 2004-06-10 IL IL162444A patent/IL162444A/en not_active IP Right Cessation
- 2004-06-16 IS IS7318A patent/IS7318A/is unknown
- 2004-06-17 ZA ZA200404802A patent/ZA200404802B/en unknown
- 2004-07-20 NO NO20043119A patent/NO329757B1/no not_active IP Right Cessation
-
2008
- 2008-02-28 US US12/039,272 patent/US7713992B2/en not_active Expired - Fee Related
-
2010
- 2010-09-08 JP JP2010200550A patent/JP2011042653A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011042653A5 (enExample) | ||
| JP2010504286A5 (enExample) | ||
| CY2017044I2 (el) | Αντισωματα εναντι cd38 για τη θεραπεια του πολλαπλου μυελωματος | |
| JP2011021016A5 (enExample) | ||
| AR062937A1 (es) | Compuestos que modulan el receptor cb2 | |
| JP2013507434A5 (enExample) | ||
| EA201700230A1 (ru) | Определенные аминопиридины, композиции на их основе и способы их применения | |
| JP2009543861A5 (enExample) | ||
| PE20080538A1 (es) | Derivado heterociclico fusionado y su uso | |
| JP2016501882A5 (enExample) | ||
| RU2016137637A (ru) | Ингибиторы вируса гепатита с и их применение в получении лекарственных средств | |
| CO6160231A2 (es) | Compuestos de isoindolina 5-substituidos | |
| RU2015145784A (ru) | Способ получения циклоалкилкарбоксамидо-индольных соединений | |
| RU2013116924A (ru) | N1/n2-лактамные ингибиторы ацетил-коа-карбоксилаз | |
| DK1613335T3 (da) | Blodkardannelse induceret af perivaskulære mesenchymale precursorceller | |
| AR087148A1 (es) | Imidazopiridazinas | |
| JP2015042636A5 (ja) | 有機化合物 | |
| PE20090290A1 (es) | Derivados de pirrolopiridina como inhibidores de bace | |
| EA201391558A1 (ru) | Тетрагидропиразоло[1,5-а]пиримидины как противотуберкулезные соединения | |
| JP2008505194A5 (enExample) | ||
| EA201171000A1 (ru) | Производные азаспиранилалкилкарбаматов в форме 5-членных гетероциклов, способ их получения и применение в терапии | |
| JP2013542213A5 (enExample) | ||
| JP2014518543A5 (enExample) | ||
| AR101132A1 (es) | Derivados de pirazina agonistas del gpr40 para el tratamiento de la diabetes tipo ii | |
| JP2014522393A5 (enExample) |